US Stock MarketDetailed Quotes

TTNP Titan Pharmaceuticals

Watchlist
  • 3.7100
  • -0.2200-5.60%
Close Nov 22 16:00 ET
  • 3.7100
  • 0.00000.00%
Post 20:01 ET
3.39MMarket Cap-558P/E (TTM)

About Titan Pharmaceuticals Company

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.

Company Profile

SymbolTTNP
Company NameTitan Pharmaceuticals
Listing DateOct 12, 2015
Founded1992
CEOMr. Brynner Chiam
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address400 Oyster Point Boulevard,Suite 505
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1958
Phone1-650-244-4990
Websitehttp://www.titanpharm.com

Company Executives

  • Name
  • Position
  • Salary
  • Brynner Chiam
  • Director, Acting Principal Executive Officer and Acting Principal Financial Officer
  • --
  • Dr. Marc Rubin,M.D.
  • Director
  • 426.25K
  • Francisco Osvaldo Flores Garcia
  • Independent Director
  • --
  • Firdauz Edmin Bin Mokhtar
  • Independent Director
  • --
  • James R. Mcnab, Jr
  • Independent Director
  • 71.36K
  • M. David MacFarlane, PhD
  • Independent Director
  • 70.11K
  • Avraham Ben-Tzvi
  • Independent Director
  • 24.38K
  • Joseph A. Akers
  • Independent Director
  • 71.36K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data